Clinical Report: Large-scale clinical trial reveals no significant differences in fluid management strategies for children with sepsis

Overview

A large NIH-supported clinical trial involving over 9,000 children found no significant differences in outcomes between balanced crystalloid and 0.9% saline fluid treatments for septic shock. Both fluid types were deemed safe and effective, providing reassurance for emergency physicians in managing pediatric sepsis.

Background

Pediatric sepsis is a critical condition that requires immediate and effective treatment to prevent severe complications, including kidney damage. The choice of intravenous fluid for resuscitation has been a topic of debate among clinicians for decades. Understanding the efficacy and safety of different fluid management strategies is essential for improving outcomes in this vulnerable population.

Data Highlights

The trial enrolled over 9,000 participants across five countries, comparing two fluid types for pediatric septic shock.

Key Findings

• No significant differences in death rates, persistent kidney dysfunction, or new renal-replacement therapy between balanced crystalloid and 0.9% saline.
• Median hospital-free days were similar for both fluid types, averaging 23 days post-enrollment.
• Children receiving 0.9% saline had higher incidences of hyperchloremia and hypernatremia.
• Balanced fluid recipients showed slightly higher incidences of hyperlactatemia.
• Results may not be generalizable to low-resource settings or hospital-acquired sepsis cases.
• Emergency physicians can confidently use either fluid type as standard care for pediatric septic shock.

Clinical Implications

The findings support the use of either balanced crystalloid or 0.9% saline for fluid resuscitation in children with septic shock, allowing for flexibility in clinical practice. Clinicians should remain aware of the biochemical differences between fluid types but can prioritize patient-centered outcomes without concern for significant differences in safety.

Conclusion

This study provides critical evidence that both fluid management strategies are effective for pediatric patients in septic shock, enhancing clinical confidence in treatment choices. Ongoing research may further clarify the applicability of these findings in varied clinical settings.

References

1. NIH, Clinical trial finds no difference in fluid treatment options for pediatric sepsis, 2026 -- Clinical trial finds no difference in fluid treatment options for pediatric sepsis
2. Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026 | Intensive Care Medicine | Springer Nature Link
3. Balanced crystalloid versus saline for resuscitation in pediatric septic shock: a systematic review and meta-analysis | BMC Pediatrics | Full Text
4. Intensive Care Medicine — Reassessing Paediatric Sepsis: Are We Revisiting Established Concepts?
5. Critical Care (Springer) — Restrictive fluid management with early de-escalation versus usual care in critically ill patients (reduce trial): a feasibility randomized controlled trial
6. Intensive Care Medicine — Review of Key Developments in Intensive Care Medicine for 2011: Focus on Cardiovascular Issues, Infections, Pneumonia, Sepsis, Critical Care Organization and Outcomes, Education, Ultrasonography, Metabolism, and Coagulation
7. Intensive Care Medicine — Enhanced cardiac output response to colloid versus saline fluid administration in critically ill patients with hypovolaemia, both septic and non-septic
8. Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026 | Intensive Care Medicine | Springer Nature Link
9. Clinical trial finds no difference in fluid treatment options for pediatric sepsis | National Institutes of Health (NIH)
10. Balanced crystalloid versus saline for resuscitation in pediatric septic shock: a systematic review and meta-analysis | BMC Pediatrics | Full Text